ID | Exposed to | FLC | PSZ | VCZ | ITR | ISA | CHX | TRC | OCT | Resistance genes | Acquired resistance mutation | Putative resistance mechanism | Overexpression of CDR1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
45 H-WT |  | 4 | 1 | 0.125 | 1 | ≤ 0.016 | 4 | 16 | 0.5 |  |  |  |  |
45 H-D6 | TRC | 256 | > 32 | 4 | > 16 | 4 | 4 | 16 | 0.5 | PDR1 | D261Y | drug efflux pumps | 50.23 |
55 H-WT |  | 4 | 0.5 | 0.125 | 0.125 | ≤ 0.016 | 4 | 4 | 0.5 |  |  |  |  |
55 H-F1 | CHX | > 256 | 4 | 1 | 2 | 1 | 16 | 16 | 1 | PMA1 | V594F | drug efflux pumps/ intracellular acidification | 65.92 |
76 H-WT |  | 4 | 0.5 | 0.25 | 0.5 | ≤ 0.016 | 8 | 8 | 0.25 |  |  |  |  |
76 H-F4 | CHX | 64 | > 32 | > 16 | 2 | 0.5 | 8 | 16 | 0.5 | PMA1/ATP1 | L347S/D332G | drug efflux pumps/ intracellular acidification | 33.32 |
105 H-WT |  | 4 | 0.5 | 0.25 | 0.5 | ≤ 0.016 | 4 | 16 | 0.5 |  |  |  |  |
105 H-E5 | CHX | 256 | 16 | 8 | > 16 | 8 | 16 | 32 | 0.5 | PMA1 | T215I | drug efflux pumps/ intracellular acidification | 38.96 |
1098 H-WT |  | 2 | 0.5 | 0.5 | 0.125 | ≤ 0.016 | 4 | 8 | 0.5 |  |  |  |  |
1098Â H-D7 | CHX | 64 | 2 | 2 | 2 | 2 | 8 | 8 | 0.25 | PMA1 | A812V | drug efflux pumps/ intracellular acidification | 45.74 |
CBS138-WT | Â | 4 | 0.25 | 0.064 | 0.25 | 0.064 | 4 | 4 | 0.5 | Â | Â | Â | Â |
CBS138-A5 | CHX | > 256 | > 32 | 8 | > 16 | 4 | 2 | 4 | 0.5 | PMA1 | A395V | intracellular acidification | 0.6 |
CBS138-E12 | CHX | 64 | 2 | 0.5 | 1 | 0.5 | 4 | 4 | 0.5 | PMA1 | D407G | intracellular acidification | 2.32 |
CBS138-A7 | TRC | 256 | 16 | 8 | > 16 | 4 | 8 | 32 | 0.5 | PDR1 | G1088E | drug efflux pumps | 23.54 |
CBS138-B4 | TRC | 256 | 4 | 8 | > 16 | 4 | 8 | 16 | 0.5 | PDR1 | G943A | drug efflux pumps | 20.18 |
CBS138-C7 | TRC | 128 | 4 | 4 | 4 | 4 | 4 | 16 | 0.5 | PDR1 | L936S | drug efflux pumps | 20.81 |
CBS138-E5 | TRC | 128 | 4 | 4 | 2 | 4 | 4 | 16 | 0.5 | PDR1 | C469R | drug efflux pumps | 9.57 |
CBS138-G10 | TRC | 128 | 4 | 2 | 4 | 2 | 4 | 16 | 0.5 | PMA1 | A395V | intracellular acidification | 2.03 |